[The toxicity and pharmacologic properties of rifampicin].
D000284:Administration, Oral; D000818:Animals; D001772:Blood Cell Count; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002415:Cats; D003864:Depression, Chemical; D004064:Digestive System / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006321:Heart / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007668:Kidney / Q000187:drug effects; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000032:analysis / Q000187:drug effects; D008112:Liver Glycogen / Q000032:analysis; D008168:Lung / Q000187:drug effects; D008297:Male; D051379:Mice; D009469:Neuromuscular Junction / Q000187:drug effects; D009929:Organ Size; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012293:Rifampin / Q000494:pharmacology / Q000633:toxicity*; D012737:Sex Factors; D013961:Thyroid Gland / Q000187:drug effects; D000637:Transaminases / Q000097:blood; D014508:Urea / Q000097:blood
D008055:Lipids; D008112:Liver Glycogen; D014508:Urea; D000637:Transaminases; D012293:Rifampin
Toksichnost' i farmakologicheskie svoĭstva rifampitsina